European

Novartis says that the U.S. and European regulators have accepted its marketing applications for CAR-T cell therapy Kymriah (Tisagenlecleucel) as third-line therapy…

The European Commission has cleared Keytruda (Pembrolizumab) in combination with chemotherapy as a first-line treatment for locally recurrent, unresectable or metastatic TNBC…

Key Point –  Aceto Pharma to acquire GMP of A&C Bio Buffer ltd  Aceto will continue to support A&C BioBuffer’s manufacturing facilities and offices…

FMC Corp. says it received U.S. Environmental Protection Agency registration for fluindapyr fungicide, which provides protection against a wide range of destructive…